For example, platelets isolated from breast cancer patients contain a higher level of VEGF and angiopoietin 1 (Ang-1), while platelets from prostate cancer patients show a greater level of VEGF but not Ang-1 [72]. Here, ANGPT1 is linked to prostate carcinoma.